The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Imatinib mesylate (IM) therapy in elderly patients affected by advanced gastrointestinal stromal tumor (GIST).
L. D'Ambrosio
No relevant relationships to disclose
A. Ponzetti
No relevant relationships to disclose
P. Lista
No relevant relationships to disclose
S. Bombaci
No relevant relationships to disclose
E. Palesandro
No relevant relationships to disclose
D. Galizia
No relevant relationships to disclose
S. Aliberti
No relevant relationships to disclose
P. Allione
No relevant relationships to disclose
A. Manca
No relevant relationships to disclose
S. Gallo
No relevant relationships to disclose
G. Grignani
No relevant relationships to disclose
M. Aglietta
No relevant relationships to disclose